- Associated Press - Tuesday, December 10, 2019

PROVIDENCE, R.I. (AP) - Researchers at Brown University and two Rhode Island hospitals announced they are researching a new drug to treat Alzheimer’s disease.

Brown, Butler Hospital and The Miriam Hospital are starting a phase-one clinical trial of emtricitabine, the three institutions announced Monday.

The drug, sold under the name Emtriva, has been used to treat HIV. Brown professor John Sedivy led a study that found that the drug may reduce age-related inflammation that has been associated with Alzheimer’s, The Providence Journal reported.

Sedivy will lead the new research with Alzheimer’s scientist and clinician Dr. Stephen P. Salloway, a neurology professor at Brown’s Warren Alpert Medical School and director of Butler Hospital’s Memory and Aging program.

Researchers plan to recruit 35 patients. Twenty-five will get the drug and 10 will get the placebo. The scientists hope to test the drug’s safety and tolerability with Alzheimer’s patients.



The research is being funded by a $750,000 grant from the Chicago-based Alzheimer’s Association.

Sign up for Daily Newsletters

Manage Newsletters

Copyright © 2020 The Washington Times, LLC.

Please read our comment policy before commenting.

 

Click to Read More and View Comments

Click to Hide